New Treatment in Australia: A Potential Breakthrough for Obesity Management ?
Australia is currently observing the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor therapy, representing a potential advance in addressing excess weight. Early research findings have demonstrated impressive results, showing greater impact than existing treatments like semagluti